Nicolás A Villagra

Dr. Nicolás A Villagra


Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 November 2021 in Molecules
Verified
Journal Article
Open access
PDF file
AMAna R. Millanao
Ana R. Millanao
AMAracely Y. Mora
Aracely Y. Mora
NVNicolás A Villagra
Nicolás A Villagra
Sergio A. BucareySergio A. Bucarey
Sergio A. Bucarey
AHAlejandro A. Hidalgo
Alejandro A. Hidalgo
Broad antibacterial spectrum, high oral bioavailability and excellent tissue penetration combined with safety and few, yet rare, unwanted effects, have made the quinolones class of antimicrobials one of the most used in inpatients and outpatients. Initially discovered during the search for improved chloroquine-derivative molecules with increased anti-malarial activity, today the quinolones, intended as antimicrobials, comprehend four generations that progressively have been extending antimicrobial spectrum and clinical use. The quinolone class of antimicrobials exerts its antimicrobial actions through inhibiting DNA gyrase and Topoisomerase IV that in turn inhibits synthesis of DNA and RNA. Good distribution through different tissues and organs to treat Gram-positive and Gram-negative bacteria have made quinolones a good choice to treat disease in both humans and animals. The extensive use of quinolones, in both human health and in the veterinary field, has induced a rise of resistance and menace with leaving the quinolones family ineffective to treat infections. This review revises the evolution of quinolones structures, biological activity, and the clinical importance of this evolving family. Next, updated information regarding the mechanism of antimicrobial activity is revised. The veterinary use of quinolones in animal productions is also considered for its environmental role in spreading resistance. Finally, considerations for the use of quinolones in human and veterinary medicine are discussed.

1 November 2016 in Infection, Genetics and Evolution
Verified
Journal Article
Closed access
AOA.P. Ortega
A.P. Ortega
NVNicolás A Villagra
Nicolás A Villagra
Ítalo M UrrutiaÍtalo M Urrutia
Ítalo M Urrutia
LVL.M. Valenzuela
L.M. Valenzuela
ATA. Talamilla-Espinoza
A. Talamilla-Espinoza
JFJuan A. Fuentes
Juan A. Fuentes

18 July 2018 in Canadian Journal of Infectious Diseases and Medical Microbiology
Verified
Journal Article
Open access
AHAlejandro A. Hidalgo
Alejandro A. Hidalgo
ÁAÁngel J. Arias
Ángel J. Arias
JFJuan A. Fuentes
Juan A. Fuentes
PGPatricia García
Patricia García
GMGuido C. Mora
Guido C. Mora
NVNicolás A Villagra
Nicolás A Villagra
Increased resistance to antimicrobials in clinically important bacteria has been widely reported. The major mechanism causing multidrug resistance (MDR) is mediated by efflux pumps, proteins located in the cytoplasmic membrane to exclude antimicrobial drug. Some efflux pumps recognize and expel a variety of unrelated antimicrobial agents, while other efflux pumps can expel only one specific class of antibiotics. Previously, we have reported that xylose decreases the efflux-mediated antimicrobial resistance inSalmonella typhimurium,Pseudomonas aeruginosa, andAcinetobacter baumannii in vitro. In this work, we assessed the effectiveness of combining xylose with antibiotics to kill resistantAcinetobacter baumanniiandKlebsiella pneumoniaein a murine model of skin infection. Skin infections were established by seeding 109bacteria onto eroded skin of mice. Mice treated with the antibiotic alone or with a mixture of glucose and antibiotics or xylose and antibiotics were compared to a control group that was infected but received no further treatment. We observed that the mixtures xylose-tetracycline and xylose-chloramphenicol produced a decrease of at least 10 times viableAcinetobacter baumanniiandKlebsiella pneumoniaerecovered from infected skin, compared with mice treated with the antibiotic alone. Our results show that xylose improves the antibiotic activity of tetracycline and chloramphenicol against efflux-mediated resistanceAcinetobacter baumanniiandKlebsiella pneumoniae, in a murine model of skin infection. We envision these combined formulations as an efficient treatment of skin infections with bacteria presenting efflux-mediated resistance, in both humans and animals.

26 January 2019 in bioRxiv
Verified
Preprint
Open access
PDF file
RERobert Edwards
Robert Edwards
AVAlejandro Vega
Alejandro Vega
HNHolly Norman
Holly Norman
MOMaria Cynthia Ohaeri
Maria Cynthia Ohaeri
KLKyle Levi
Kyle Levi
BDBas E. Dutilh
Bas E. Dutilh
Microbiomes are vast communities of microbes and viruses that populate all natural ecosystems. Viruses have been considered the most variable component of microbiomes, as supported by virome surveys and examples of high genomic mosaicism. However, recent evidence suggests that the human gut virome is remarkably stable compared to other environments. Here we investigate the origin, evolution, and epidemiology of crAssphage, a widespread human gut virus. Through a global collaboratory, we obtained DNA sequences of crAssphage from over one-third of the world's countries, and showed that its phylogeography is locally clustered within countries, cities, and individuals. We also found colinear crAssphage-like genomes in both Old-World and New-World primates, challenging genomic mosaicism and suggesting that the association of crAssphage with primates may be millions of years old. We conclude that crAssphage is a benign globetrotter virus that may have co-evolved with the human lineage and an integral part of the normal human gut virome.

21 January 2026 in Antibiotics
Verified
Journal Article
Open access
PDF file
AHAlejandro A. Hidalgo
Alejandro A. Hidalgo
Sergio A. BucareySergio A. Bucarey
Sergio A. Bucarey
BSBeatriz Sepulveda
Beatriz Sepulveda
SCSebastián Cumsille-Escandar
Sebastián Cumsille-Escandar
ACAlejandro Charmell
Alejandro Charmell
MRMaité Rodríguez-Díaz
Maité Rodríguez-Díaz
Background/Objectives: The genus Tristerix comprises at least ten species, found from southern Chile to Colombia in South America. In Chile, several species of these hemiparasitic plants are known as quitral or quintral. Quitral, mainly T. corymbosus (syn. T. tetrandus), is used in alternative medicine for its anti-inflammatory, digestive, hemostatic, hypocholesterolemic, and wound-healing properties. This study investigates the phytochemical composition and antimicrobial properties of T. corymbosus. Methods: A hydroalcoholic extract of T. corymbosus was prepared from leaves and small branches. The addition of methanol, on the extract, produced precipitation allowing us to isolate a methanol-soluble fraction, a brown powder obtained after filtration, and a tar-like residue remaining in the flask. These fractions were resuspended and tested for antimicrobial activity. Results: All fractions showed activity against Streptococcus pyogenes, but not E. coli. The brown powder exhibits the strongest potency against Gram-positive bacteria, some Gram-negative and C. albicans. HPLC-MS analysis revealed presence of lipidic compounds with surfactant properties. Conclusions: The abundant lipidic molecules present in the analyzed fraction likely account for the antimicrobial effects through affecting membrane structure of microorganisms supporting the traditional wound-healing uses of T. corymbosus in ancestral medicine.

15 December 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
AHAlejandro A. Hidalgo
Alejandro A. Hidalgo
Sergio A. BucareySergio A. Bucarey
Sergio A. Bucarey
BSBeatriz Sepulveda
Beatriz Sepulveda
SCSebastián Cumsille-Escandar
Sebastián Cumsille-Escandar
ACAlejandro Charmell
Alejandro Charmell
MRMaité Rodríguez-Díaz
Maité Rodríguez-Díaz
Background/Objectives: The genus Tristerix comprises at least ten species, found from southern Chile to Colombia in South America. In Chile, several species of these hemiparasitic plants are commonly known as quitral or quintral. Traditionally, quitral, mainly T. corymbosus (syn. T. tetrandus), has been used in alternative medicine for its anti-inflammatory, digestive, hemostatic, hypocholesterolemic, wound-healing, and astringent properties. Due to its wide distribution in central and southern Chile and its frequent collection for ethnopharmacological purposes, this study aimed to investigate the phytochemical composition and antimicrobial properties of T. corymbosus. Methods: A hydroalcoholic extract of T. corymbosus was prepared from powdered leaves and small branches. Subsequently, the addition of methanol produced a precipitation to isolate three different fractions: a methanol-soluble fraction that was rotovaped, a brown powder obtained after filtration, and a tar-like residue that remained at the bottom of the flask. These fractions were resuspended in 70% ethanol or water and tested for antimicrobial activity. Results: All fractions showed activity against Streptococcus pyogenes, but not E. coli, with the brown powder exhibiting the strongest potency against S. pyogenes and other Gram-positive bacteria. Qualitative phytochemical characterization, followed by HPLC-MS analysis, revealed the presence of key compounds, including lipidic compounds with surfactant properties. Conclusions: the abundant lipidic molecules present in the analyzed fraction likely account for the antimicrobial effects through affecting membrane structure of Gram-positive bacteria, some Gram-negative and yeast Candida albicans supporting the traditional wound-healing uses of T. corymbosus in ancestral and alternative medicine.